Dexmedetomidine	B:C0113293
Effect	O
on	O
Emergence	O
Agitation	I:C0920253
and	O
Delirium	O
in	O
Children	O
Undergoing	O
Laparoscopic	O
Hernia	I:C2111384
Repair	I:C2111384
:	O
a	O
Preliminary	O
Study	O
.	O

Dexmedetomidine	O
Effect	O
on	O
Emergence	B:C0920253
Agitation	I:C0920253
and	O
Delirium	O
in	O
Children	O
Undergoing	O
Laparoscopic	O
Hernia	I:C2111384
Repair	I:C2111384
:	O
a	O
Preliminary	O
Study	O
.	O

Dexmedetomidine	O
Effect	O
on	O
Emergence	O
Agitation	I:C0920253
and	O
Delirium	B:C0011206
in	O
Children	O
Undergoing	O
Laparoscopic	O
Hernia	I:C2111384
Repair	I:C2111384
:	O
a	O
Preliminary	O
Study	O
.	O

Dexmedetomidine	O
Effect	O
on	O
Emergence	O
Agitation	I:C0920253
and	O
Delirium	O
in	O
Children	O
Undergoing	O
Laparoscopic	B:C2111384
Hernia	I:C2111384
Repair	I:C2111384
:	O
a	O
Preliminary	O
Study	O
.	O

Dexmedetomidine	O
Effect	O
on	O
Emergence	O
Agitation	I:C0920253
and	O
Delirium	O
in	O
Children	O
Undergoing	O
Laparoscopic	O
Hernia	I:C2111384
Repair	I:C2111384
:	O
a	O
Preliminary	O
Study	B:C2603343
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	B:C0113293
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	B:C0113293
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	B:C0920253
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	B:C0920253
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	B:C0011206
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	B:C0011206
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	B:C2111384
hernia	I:C2111384
repair	I:C2111384
under	O
general	O
anesthesia	I:C0002915
.	O

To	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
dexmedetomidine	O
(	O
dexmedetomidine	O
)	O
to	O
prevent	O
emergence	O
agitation	I:C0920253
(	O
emergence	O
agitation	I:C0920253
)	O
and	O
delirium	O
(	O
ED	O
)	O
in	O
children	O
undergoing	O
laparoscopic	O
hernia	I:C2111384
repair	I:C2111384
under	O
general	B:C0002915
anesthesia	I:C0002915
.	O

Methods	O
100	O
children	O
(	O
1	O
-	O
5	O
years	O
,	O
10	O
-	O
25	O
kg	O
)	O
were	O
randomized	B:C0034656
into	O
four	O
groups	O
:	O
controls	O
(	O
saline	O
)	O
and	O
intravenous	O
dexmedetomidine	O
at	O
0.25	O
,	O
0.5	O
,	O
and	O
1.0	O
µg/kg	O
(	O
D1	O
,	O
D2	O
,	O
D3	O
,	O
respectively	O
)	O
.	O

Methods	O
100	O
children	O
(	O
1	O
-	O
5	O
years	O
,	O
10	O
-	O
25	O
kg	O
)	O
were	O
randomized	O
into	O
four	O
groups	O
:	O
controls	O
(	O
saline	O
)	O
and	O
intravenous	B:C0348016
dexmedetomidine	O
at	O
0.25	O
,	O
0.5	O
,	O
and	O
1.0	O
µg/kg	O
(	O
D1	O
,	O
D2	O
,	O
D3	O
,	O
respectively	O
)	O
.	O

Methods	O
100	O
children	O
(	O
1	O
-	O
5	O
years	O
,	O
10	O
-	O
25	O
kg	O
)	O
were	O
randomized	O
into	O
four	O
groups	O
:	O
controls	O
(	O
saline	O
)	O
and	O
intravenous	O
dexmedetomidine	B:C0113293
at	O
0.25	O
,	O
0.5	O
,	O
and	O
1.0	O
µg/kg	O
(	O
D1	O
,	O
D2	O
,	O
D3	O
,	O
respectively	O
)	O
.	O

dexmedetomidine	B:C0113293
/	O
saline	O
infusion	O
was	O
started	O
following	O
anesthesia	O
.	O

dexmedetomidine	O
/	O
saline	O
infusion	B:C0574032
was	O
started	O
following	O
anesthesia	O
.	O

dexmedetomidine	O
/	O
saline	O
infusion	O
was	O
started	O
following	O
anesthesia	B:C4049933
.	O

emergence	B:C0920253
agitation	I:C0920253
and	O
ED	O
were	O
evaluated	O
on	O
a	O
5	O
-	I:C0282574
point	I:C0282574
scale	I:C0282574
.	O

emergence	O
agitation	I:C0920253
and	O
ED	B:C0011206
were	O
evaluated	O
on	O
a	O
5	O
-	I:C0282574
point	I:C0282574
scale	I:C0282574
.	O

emergence	O
agitation	I:C0920253
and	O
ED	O
were	O
evaluated	O
on	O
a	O
5	B:C0282574
-	I:C0282574
point	I:C0282574
scale	I:C0282574
.	O

For	O
the	O
C	O
,	O
D1	O
,	O
D2	O
,	O
and	O
D3	O
groups	O
,	O
respectively	O
,	O
emergence	B:C0920253
agitation	I:C0920253
frequencies	O
were	O
45.8	O
%	O
,	O
30.4	O
%	O
,	O
12	O
%	O
,	O
4	O
%	O
;	O
ED	O
frequencies	O
29.1	O
%	O
,	O
13	O
%	O
,	O
4	O
%	O
,	O
4	O
%	O
;	O
CHIPPS	O
scores	O
8	O
,	O
6	O
,	O
3	O
,	O
3	O
;	O
sevoflurane	O
doses	O
from	O
13.2	O
±	O
3.4	O
(	O
controls	O
)	O
to	O
9.4	O
±	O
3.5	O
ml	O
(	O
D3	O
)	O
.	O

For	O
the	O
C	O
,	O
D1	O
,	O
D2	O
,	O
and	O
D3	O
groups	O
,	O
respectively	O
,	O
emergence	O
agitation	I:C0920253
frequencies	O
were	O
45.8	O
%	O
,	O
30.4	O
%	O
,	O
12	O
%	O
,	O
4	O
%	O
;	O
ED	B:C0011206
frequencies	O
29.1	O
%	O
,	O
13	O
%	O
,	O
4	O
%	O
,	O
4	O
%	O
;	O
CHIPPS	O
scores	O
8	O
,	O
6	O
,	O
3	O
,	O
3	O
;	O
sevoflurane	O
doses	O
from	O
13.2	O
±	O
3.4	O
(	O
controls	O
)	O
to	O
9.4	O
±	O
3.5	O
ml	O
(	O
D3	O
)	O
.	O

For	O
the	O
C	O
,	O
D1	O
,	O
D2	O
,	O
and	O
D3	O
groups	O
,	O
respectively	O
,	O
emergence	O
agitation	I:C0920253
frequencies	O
were	O
45.8	O
%	O
,	O
30.4	O
%	O
,	O
12	O
%	O
,	O
4	O
%	O
;	O
ED	O
frequencies	O
29.1	O
%	O
,	O
13	O
%	O
,	O
4	O
%	O
,	O
4	O
%	O
;	O
CHIPPS	B:C1504479
scores	O
8	O
,	O
6	O
,	O
3	O
,	O
3	O
;	O
sevoflurane	O
doses	O
from	O
13.2	O
±	O
3.4	O
(	O
controls	O
)	O
to	O
9.4	O
±	O
3.5	O
ml	O
(	O
D3	O
)	O
.	O

For	O
the	O
C	O
,	O
D1	O
,	O
D2	O
,	O
and	O
D3	O
groups	O
,	O
respectively	O
,	O
emergence	O
agitation	I:C0920253
frequencies	O
were	O
45.8	O
%	O
,	O
30.4	O
%	O
,	O
12	O
%	O
,	O
4	O
%	O
;	O
ED	O
frequencies	O
29.1	O
%	O
,	O
13	O
%	O
,	O
4	O
%	O
,	O
4	O
%	O
;	O
CHIPPS	O
scores	O
8	O
,	O
6	O
,	O
3	O
,	O
3	O
;	O
sevoflurane	B:C0074414
doses	O
from	O
13.2	O
±	O
3.4	O
(	O
controls	O
)	O
to	O
9.4	O
±	O
3.5	O
ml	O
(	O
D3	O
)	O
.	O

Intervals	O
until	O
mask	B:C0024861
removal	O
/	O
spontaneous	O
eye	I:C1882151
opening	I:C1882151
were	O
significantly	O
longer	O
for	O
D2	O
and	O
D3	O
than	O
controls	O
.	O

Intervals	O
until	O
mask	O
removal	O
/	O
spontaneous	B:C1882151
eye	I:C1882151
opening	I:C1882151
were	O
significantly	O
longer	O
for	O
D2	O
and	O
D3	O
than	O
controls	O
.	O

PACU	B:C0034871
stay	O
was	O
longer	O
for	O
D3	O
.	O

There	O
was	O
significantly	O
less	O
postoperative	O
emergence	B:C0920253
agitation	I:C0920253
and	O
pain	O
,	O
with	O
less	O
sevoflurane	O
required	O
,	O
using	O
dexmedetomidine	O
.	O

There	O
was	O
significantly	O
less	O
postoperative	O
emergence	O
agitation	I:C0920253
and	O
pain	B:C0030201
,	O
with	O
less	O
sevoflurane	O
required	O
,	O
using	O
dexmedetomidine	O
.	O

There	O
was	O
significantly	O
less	O
postoperative	O
emergence	O
agitation	I:C0920253
and	O
pain	O
,	O
with	O
less	O
sevoflurane	B:C0074414
required	O
,	O
using	O
dexmedetomidine	O
.	O

There	O
was	O
significantly	O
less	O
postoperative	O
emergence	O
agitation	I:C0920253
and	O
pain	O
,	O
with	O
less	O
sevoflurane	O
required	O
,	O
using	O
dexmedetomidine	B:C0113293
.	O

